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Several studies have demonstrated that there are genetic
influences on free-choice oral nicotine consumption in
mice. In order to establish the genetic architecture that
underlies individual differences in free-choice nicotine
consumption, quantitative trait loci (QTL) mapping was
used to identify chromosomal regions that influence
free-choice nicotine consumption in male and female F2
mice derived from a cross between C57BL/6J and C3H/
HeJmice. These twomouse strainswere chosen not only
because they differ significantly for oral nicotine con-
sumption, but also because they are at or near pheno-
typic extremes for all measures of nicotine sensitivity
that have been reported. A four-bottle choice paradigm
was used to assess nicotine consumption over an 8-day
period. The four bottles contained water or water sup-
plemented with 25, 50 or 100 mg/ml of nicotine base.
Using micrograms of nicotine consumed per milliliter of
total fluid consumed per day as the nicotine consump-
tion phenotype, four significant QTL were identified. The
QTL with the largest LOD score was located on distal
chromosome 1 (peak LOD score 5 15.7). Other chromo-
somes with significant QTL include central chromosome
4 (peak LOD score 5 4.1), proximal chromosome 7 (peak
LOD score 5 6.1) and distal chromosome 15 (peak LOD
score5 4.8). These four QTL appear to be responsible for
up to 62% of the phenotypic variance in oral nicotine
consumption.
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Genetic factors appear to be important determinants that
influence whether or not an individual will become a regular
smoker. Twin studies, beginning with those of Fisher (Fisher
1958a; 1958b), have demonstrated that the heritability of
smoking ranges from 0.2 to 0.8 with a mean estimate of
heritability of 0.53 (Sullivan and Kendler, 1999; Li 2003). In
other words, approximately 50% of the variance of whether
an individual is a smoker can be attributed to genetic factors.
Genetic factors influence multiple aspects of tobacco use
including initiation (Heath et al. 1993), persistence (Heath
1990; Heath and Martin 1993), number of cigarettes smoked
(Carmelli et al. 1990) and the ability to stop smoking (Carmelli
et al. 1992). Due to the considerable genetic influence on
smoking-related behaviors, several groups have attempted to
identify susceptibility loci for nicotine addiction/dependence.
These studies have ranged from candidate gene association
studies to genome-wide linkage analyses (see Li, 2006, for
recent review). Although considerable progress is being
made in this arena, the identification of genes that influence
liability to nicotine addiction has proven difficult, at best. This
may be due to the many complications including lack of
environmental control, the use of different instruments to
assess nicotine dependence and disparities in defining nico-
tine addiction.
Like smoking behavior in humans, the behavioral and
physiological effects of nicotine in mice are influenced by
genetic factors. For example, Marks et al. demonstrated that
there is a two- to six-fold difference in ED50 values for
a battery of tests for nicotine sensitivity across 19 inbred
strains (Marks et al. 1989). Miner and Collins (1989) reported
similar results for nicotine-induced seizure sensitivity for the
same 19 inbred strains. Genetic influences on the develop-
ment of tolerance to nicotine (Marks et al. 1991), nicotine oral
self-selection (Robinson et al. 1996; Butt et al. 2005; Li et al.
2005) and conditioned place preference (Schechter et al.
1995) also have been reported. Heritability estimates for
some of these behaviors were obtained and found to range
from 0.3 (for nicotine-induced hypothermia; Marks et al. 1984)
to 0.63 (for nicotine-induced seizure sensitivity; Miner et al.
1984). One of the aforementioned behaviors, nicotine oral
self-selection is a measure that assesses free-choice nicotine
consumption. Although this measure clearly is not a direct
model of smoking, it does possess several features similar to
the smoking phenotype. For example, nicotine consumption
occurs intermittently through the normal awake period and
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sparingly during the normal sleep phase. In addition, similar to
what is observed in humans, chronic oral nicotine consump-
tion leads to tolerance development to the effects of nicotine
and an increase in the number of high affinity nicotinic
receptors in brain (Sparks and Pauly 1989). Moreover,
Brunzell et al. (2003) demonstrated that chronic oral nicotine
consumption leads to alterations in the expression of genes in
signaling pathways thought to contribute to the addiction pro-
cess. Also similar to what is observed in humans, there are
significant differences in the willingness of mice to consume
nicotine. Some mouse strains avoid nicotine nearly completely
while others consume significant levels of the drug (Robinson
et al. 1996; Butt et al. 2005; Li et al. 2005; Siu et al. 2006).
Based upon these observations, it seems reasonable that
identification of genes that influence individual differences in
oral nicotine consumption in the mouse may provide some
insight into the genetic architecture of nicotine dependence in
humans. In the study reported here, quantitative trait loci
(QTL) mapping was used to identify chromosomal loci that
influence free-choice nicotine consumption in an F2 intercross
between C57BL/6J and C3H/HeJ. These two mouse strains
are near phenotypic extremes for nearly every measure of
nicotine sensitivity assessed, including oral nicotine con-
sumption (Marks et al. 1989, 1991; Miner and Collins 1989;
Robinson et al. 1996; Butt et al. 2005; Li et al. 2005). Results
indicate that there are at least four significant QTL that
influence nicotine consumption in this population. Moreover,
these four QTL appear to be responsible for up to 62% of the
phenotypic variance in oral nicotine consumption.
Methods
Animals
C57BL/6J  C3H/HeJ F2 intercross mice were used for QTL
analysis. In order to generate the F2 population, F1 mice were
first produced by reciprocal crosses between the parental
strains. F1 mice were then crossed in all pairwise combina-
tions to produce the F2 intercross animals. Mice were
weaned at 21 days of age and housed with same sex siblings
with free access to food and water. The mice were main-
tained on a 12h:12h light/dark cycle with lights on at 0600 h
and lights off at 1800 h. All animal care and experimental
procedures were approved by and performed in accordance
with the guidelines of the Animal Care and Utilization Com-
mittees of the University of the University of Michigan, Ann
Arbor, MI, and the University of Colorado, Boulder, CO.
Nicotine consumption
Nicotine consumption was measured using the four-bottle
choice paradigm. Briefly, mice were individually housed with
free access to food and provided with four water bottles, one
that contained water only and three that contained water
supplemented with different concentrations of nicotine. The
nicotine concentrations used were 25, 50 and 100 mg/ml.
New or freshly distilled () nicotine free base (Sigma-Aldrich,
St Louis, MO) was used for solution preparations. Each day
the position of the bottles were rotated to eliminate prefer-
ence based on the location of the bottle. The test was
conducted for 8 days so that each bottle was located in each
of the four possible positions twice. A set of dummy bottles
(bottles with liquid placed in cages with no mice) were
included in each round of testing in order to assess liquid
loss due to evaporation and general handling. Fluid consump-
tion values were adjusted for this non-specific fluid loss. The
bottles were weighed at the beginning and end of each 4-day
trial and the volume consumed from each drinking solution
was determined. The mice were weighed on the first, fifth
and last day of the experiment. Nicotine consumption (in mg)
per day was determined by multiplying the concentration of
nicotine solution times the volume of nicotine consumed
from each concentration per day. The daily amount of
nicotine consumed from the 25, 50 and 100 mg/ml nicotine-
containing bottles was summed to give a total consumption
value. Overall nicotine consumption was calculated as micro-
grams of nicotine consumed per milliliter of total fluid con-
sumed per day (total nicotine consumed per day divided by
total fluid consumption per day) and dose of nicotine consumed
per day (total nicotine consumed/day divided by the average
weight of the mice). A total of 584 mice were tested in groups
of approximately 50mice at approximately 2-week intervals per
group. Mice in each test group were matched by age and
approximately equal numbers of male and female mice were
included per group. Testing was initiated between 55 and 65
days of age.
Genotyping
F2 animals with the highest and lowest consumption values
were chosen for genotypic analysis. A total of 203 animals,
107 male and 96 female mice, were genotyped. DNA was
extracted from splenic tissue from these mice by overnight
digestion in a solution of 10 mM Tris, pH 8, 5 mM ethyl-
enediaminetetraacetic acid (EDTA), pH 8, 100 mM NaCl, 0.5%
sodium dodecyl sulphate and 100 mg/ml proteinase K, ex-
tracted with an equal volume of phenol : chloroform : isoamyl
alcohol (25:24:1) and precipitated by the addition of one
volume of isopropyl alcohol. The samples were resuspended
in TE (10 mM Tris, pH 8, 1 mM EDTA, pH 8). For genotyping,
microsatellite marker-specific polymerase chain reaction
(PCR) primers (0.45 mM each) (MapPairs, Research Genetics/
Invitrogen, Carlsbad, CA, USA) were included in a 7.5-ml
reaction that contains 40 ng DNA, 1 PCR buffer (Amplitaq
Gold buffer II), 0.25 mM dNTP mix, 2.5 mM MgCl2 and 0.3 U
AmpliTag Gold DNA polymerase (Applied Biosystems,
Branchburg, NJ, USA). Samples were amplified in either an
MJ Research PTC-100 thermal cycler (Bio-Rad, Hurcules, CA,
USA) or a Bio-Rad iCycler thermal cycler according to the
conditions recommended by Research Genetics (958C for
12 min followed by 10 cycles of 948C for 15 seconds, 558C for
15 seconds, 728C for 15 seconds followed by an additional 20
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cycles of 898C for 15 seconds, 558C for 15 seconds, 728C for
15 seconds and completed by 728C for 7 min). Samples were
electrophoresed on 3–4% Metaphor agarose (Cambrex,
Rockland, ME, USA) gels, stained with ethidium bromide
and genotypes were determined by visual inspection by at
least two independent observers. Eighty markers were used
for genotyping including 77 microsatellite markers and 3
single nucleotide polymorphism (SNP) markers. The micro-
satellite markers were selected from the Mouse Genome
Informatics Database (www.informatics.jax.org) and were all
markers from the Massachusetts Institute of Technology
collection. The SNP markers were chosen to fill in gaps on
distal chromosome 2, proximal chromosome 7 and central
chromosome 15. They were selected using the Oxford
mouse SNP database (the markers used were all polymorphic
between C57BL/6J and C3H/HeJ mice and each SNP re-
sulted in a unique restriction site that was used to identify
each allele). The markers were chosen to produce an average
inter-marker interval of approximately 20 cM.
Data analysis
Data were analyzed using Map Manager QTX (Manly et al.
2001). Initially, permutation analysis (1000 permutations at 1
cM intervals) was performed on the data to empirically
estimate thresholds for suggestive, significant and highly
significant QTL (Churchill and Doerge 1994). Essentially, in
this test the trait values are randomly permuted among the
progeny, destroying any relationship between the trait values
and the genotypes of the marker loci. The regression model is
fitted for the permuted data at multiple analysis points across
the genome (matching the points used for detecting QTLs)
and the maximum LRS is recorded. This procedure is
repeated a thousand times, giving a distribution of statistic
values, which wewould expect if there were no QTL linked to
any of the marker loci. The threshold values of the permuta-
tion test, which are labeled suggestive, significant and highly
significant are taken from the guidelines of Lander and
Kruglyak (1995) and correspond to the 37th, 95th and
99.9th percentiles, respectively. These thresholds corres-
pond to genome-wide a values of 0.63, 0.05 and 0.001,
respectively. For the mg/ml consumption data, thresholds
were estimated as LOD 2.0 for suggestive, LOD 3.38 for
significant and LOD 4.97 for highly significant. Once genome-
wide thresholds were estimated, regression analysis using
the free model was utilized to identify markers that were
associated with the nicotine consumption phenotypes.
We also performed regression analysis separately for each
sex and utilized themethod previously described by Bergeson
et al. (2003) to identify sex-specific or sex-influenced QTL.
Briefly, the marker LOD scores for each sex were subtracted
from one another, and this difference in LOD score between
female and male mice was converted back to a P value. The
calculated P value is an estimate of P for the sex difference.
Interconverting LOD and P were done by using the formulas
LOD ¼ log10(P) or P ¼ 10LOD. Because 15 provisional QTL
were searched in the F2 for gender differences, we used
a Bonferroni correction of 15-fold. Therefore, the significance
threshold was defined as P ¼ 0.05/15 or P ¼ 0.003. This
converts into a LOD score difference of 2.5 as the threshold
for a sex difference. Any QTL that met or exceeded the 2.5
LOD difference between sexes were further defined as sex-
specific if the marker exceeded the significance threshold in
one sex only or sex-influenced if the marker surpassed the
significance threshold in both sexes.
Interval mapping was performed on chromosomes con-
taining at least one marker that met the significant threshold.
All mapping methods used by Map Manager QTX are based
upon the Maximum Likelihood approach of Lander and
Botstein (1989). Data also were evaluated using QTL Cartog-
rapher (Wang et al. 2005b) with essentially identical results.
Results
Nicotine consumption in C57BL/6J 3 C3H/HeJ F2
intercross mice
A total of 584 BxH F2 mice (306 female and 278 male) were
tested for nicotine consumption in a four-bottle choice para-
digm as described in the Methods. The main phenotypic
measure used to assess average daily nicotine consumption
wasmicrograms of nicotine consumed permilliliter of total fluid
consumed per day (mg/ml/day). When using this measure, no
sex differences in nicotine consumption were observed
(16.1  0.42 and 15.7  0.44 mg/ml/day for female and male
mice, respectively (t ¼ 0.625, P > 0.5)) (Fig. 1a). In addition,
there were no sex differences in daily total fluid consumption
(6.30 0.06 and 6.28 0.06ml/day for female and male mice,
respectively (t ¼ 0.378, P ¼ 0.71)) (Fig. 1b). However, for
a second measure of nicotine consumption, the mean dose of
nicotine consumed, sex differences were noted. The daily
dose of nicotine consumed by female mice (4.7  0.12 mg/kg/
day) was significantly greater (t ¼ 8.28, P < 0.001) than the
dose consumed by male mice (3.37  0.10 mg/kg/day) (Fig. 1
a). For both measures of nicotine ingestion, the data were
skewed toward low nicotine consumption (Fig. 2) while total
fluid consumption exhibited a normal distribution (Fig. 3).
Identification of QTL related to nicotine
consumption
To locate chromosomal loci that are associated with nicotine
consumption, 203 animals (100 female, 103 male) at the
phenotypic extremes (96 from the low consumption extreme
and 107 from the high consumption extremes) were geno-
typed for 80 markers across all 19 autosomal chromosomes.
Primary analyses to identify QTL were performed for the
micrograms of nicotine consumed per milliliter of total fluid
measure because there was no sex difference for this
phenotype. The mean nicotine consumption from the low
and high end extremes was 8.5 0.15 and 25.1 0.63 mg/ml/
day, respectively.
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Regression analysis
Permutation analysis of the data from the phenotypic extremes
established empirical LOD score values of 2.0, 3.4 and 5.0 as
thresholds for suggestive, significant and highly significantQTL.
Fifteen markers were identified that are associated with
nicotine consumption at the suggestive LOD score value of
2.0 or greater (Table 1). The list of markers includes three each
on chromosomes 1, 4 and 15, four on chromosome 7 and one
each on chromosomes 14 and 18. Regression analysis alsowas
performed on each sex separately (Table 1). Although no
additional QTL were detected, it was ascertained that of the
15 QTL identified in combined sex data, 2 meet the criteria
defined in the methods for sex-specific QTL (D1MIT308
and D4MIT175) and 1meets the criteria defined in themethods





































































Figure 1: Influence of sex of mice on phenotypic measures.
(a) No effect of sex was observed when micrograms of nicotine
consumed per milliliter of total fluid consumed per day was used
as the phenotypic measure. (b) Daily fluid consumption (nicotine
plus water) also was not different between male and female
mice. (c) A significant effect of sex (P < 0.001) was detected
when dose of nicotine consumed (mg/kg/day) was used as the
phenotypic variable for nicotine consumption. ***P< 0.001. Data
presented represent mean  SEM.
Skewness = 1.29 ± 0.101
































Skewness = 0.998 ± 0.102
Kurtosis = 0.584 ± 0.203  
Figure 2: Distribution of nicotine consumption in 584
C57BL/6JC3H/HeJ F2 intercrossmice.Nicotine consumption
when measured either by mg/ml/day (a) or mg/kg/day (b) of
nicotine drank per day exhibits a distribution that is positively
skewed. The mean amount of nicotine consumed for the two
measures, respectively, was 15.88  0.30 mg/ml/day and 4.08 
0.084 mg/kg/day. The solid line represents a normal distribution.
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chromosomes 1, 4, 14, 15 and 18, the C57BL/6 allele was
associated with higher nicotine consumption. In contrast, for
each marker on chromosome 7, the C3H/HeJ allele was
associated with greater nicotine consumption. The relationship
between the markers on each chromosome with the highest
LOD score and nicotine consumption (mg/ml/day data are
shown) is shown in Fig. 4. When the same regression analyses
were performed for dose, nearly identical resultswere obtained
(data not shown).
Interval mapping for both measures of nicotine
consumption
Chromosomes for which at least one marker was identified
as being significantly associated with nicotine consumption
were further evaluated by interval mapping. Due to the
positive skewing of the raw phenotypic data, log transforms
of the data were used for interval mapping. Using the free
regressionmodel for interval mapping, highly significant QTLs
for micrograms of nicotine consumed per milliliter of total
fluid were identified on distal chromosome 1 (peak LOD score
¼ 15.7) and proximal chromosome 7 (peak LOD score ¼ 6.1),
while significant QTLs were found on central chromosome 4
(peak LOD score¼ 4.1) and distal chromosome 15 (peak LOD
score ¼ 4.8) (Fig. 5). The estimated percentage of the
phenotypic variance that can be explained by the QTL on
chromosomes 1, 4, 7 and 15 was 30%, 9%, 13% and 10%,
respectively. Interval mapping also was performed on the
data from each sex for chromosomes 1 and 4 because QTL
on these chromosomes appear to be either sex-influenced or
sex-dependent (Fig. 5a,b). Interval mapping using dose as the
phenotype yielded essentially identical results although with
slightly lower peak LOD scores (Chr 1, LOD ¼ 12.6; Chr 4,
LOD ¼ 4.4; Chr 7, LOD ¼ 4.6; Chr 15, LOD ¼ 4.4).
Discussion
Four significant QTL for nicotine consumption have been
identified in F2 intercross mice derived from the parental
strains C57BL/6J and C3H/HeJ. The significant QTL are
located on chromosomes 1, 4, 7 and 15. Each of the four
121086420













Skewness = 0.277 ± 0.102
Kurtosis = 3.19 ± 0.203
Figure 3: Distribution of total fluid consumption. Total fluid
consumption (ml nicotine solutions consumed plus ml water
consumed) exhibits a normal distribution in the F2 animals. Mean
fluid consumption was 6.34  0.09 ml/day. The solid line
represents a normal distribution.












1 D1MIT308 62.1 6.25 1.11 6.14 5.03
1 D1MIT206 95.8 15.38 10.2 4.27 5.93
1 D1MIT511 109.6 7.92 3.45 3.14 0.31
4 D4MIT175 49.6 3.93 4.32 0.82 3.5
4 D4MIT203 60 2.47 2.54 0.46 2.08
4 D4MIT42 81 2.54 2.32 0.63 1.69
7 rs13479172 13 5.18 2.95 2.17 2.78
7 D7MIT228 18 5.90 2.65 3.56 0.91
7 D7MIT91 28.1 2.97 1.06 2.23 1.17
7 D7MIT323 50 2.54 1.48 1.65 1.7
14 D14MIT39 30 2.23 0.59 1.34 0.75
15 D15M70 47.7 3.99 2.62 2.60 0.02
15 rs3667785 56 4.47 3.73 1.65 2.08
15 D15M161 69.2 3.77 3.90 1.63 2.27
18 D18MIT7 50 2.62 2.0 0.15 1.85
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QTL was detected using two different measures of nicotine
consumption (mg nicotine/ml fluid or nicotine dose). Although
numerous studies have identified QTL for oral consumption of
drugs of abuse in animal models (for review see Crabbe et al.
1999 and Flint 2003), this is the first report of the identification
of QTL for nicotine consumption in an animal model. The
results of this study also indicate that as much as 62% of















































































































































Figure 4: Association between some significant markers and nicotine consumption.Markers on six chromosomes (1, 4, 7, 14, 15
and 18) were detected at a LOD score of 2.0 or greater. The relationship betweenmarkers with the highest LOD scores on each of the six
chromosomes is shown. (a) Markers with highest LOD scores which are not sex-specific. Data from all F2 extremes are included. (b) The
two significant markers that meet the criteria as sex-specific quantitative trait loci were plotted using data from either male (D1MIT308)
or female (D4MIT175) animals only. Data represent mean  SEM. BB, homozygous for the C57BL/6 allele of the marker; BH,
heterozygous for the marker; HH, homozygous for the C3H allele of the marker. The identity of the evaluated marker is indicated above
each graph. LOD scores for each marker can be found in Table 1.
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the four significant QTL. Thus, oral nicotine consumption
appears to be under a strong genetic influence. These results
are consistent with studies in humans that indicate that approxi-
mately 56% of the variance in smoking initiation (Sullivan and
Kendler 1999) and up to 70% of the variance in nicotine
dependence (Kendler et al. 1999; True et al. 1999) can be
attributed to genetic factors. Moreover, the largest peak LOD
score identified for nicotine consumption in mice is located at
around 96 cM on mouse chromosome 1. This region of the
mouse genome is syntenic with human chromosome 1 at
around 169 cM. To date, the QTL with the greatest effect on
nicotine dependence identified in humans is located on
human chromosome 1 with a confidence interval of between
168 and 196 cM (Wang et al. 2005a). Two additional studies
also have identified potential QTL for nicotine dependence in
humans located within this region of chromosome 1 (Bergen
and Caporaso 1999; Goode et al. 2003). Thus, in both mice
and humans, the same genomic region appears to influence
nicotine consumption/dependence.
The markers for the significant QTL on chromosomes 1, 4
and 15 were associated with nicotine consumption in a
manner consistent with parental nicotine consumption (Li
et al. 2005); mice homozygous for the C57BL/6 allele con-
sumed the most nicotine on average while mice homozygous
for the C3H allele consumed the least amount of nicotine on
average. In contrast, markers for the significant QTL on
chromosome 7 showed the opposite pattern. Mice homozy-
gous for the C3H marker allele consumed more nicotine than
did mice homozygous for the C57BL/6 allele. Therefore,
despite the fact that C57BL/6 mice consume the most
nicotine of any mouse strain evaluated (Robinson et al.
1996; Butt et al. 2005; Li et al. 2005), they do not carry all
of the alleles for high nicotine consumption.
The results of this study also suggest that there are sex-
influenced as well as sex-specific QTL for nicotine consump-
tion even though sex differences were not observed in
the main phenotype used to assess nicotine consumption
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Figure 5: Interval mapping of quantitative trait loci (QTL) on chromosomes 1, 4, 7 and 15. Interval mapping was performed using
Map Manager QTX. LOD scores represent the results of a model independent (free) interval analysis. The x-axis represents the
approximate genetic map of each chromosome in centiMorgans (cM). The short-dashed line represents the LOD score threshold for
a significant QTL and the long-dashed line represents the LOD score threshold for a highly significant QTL. Significance thresholds were
determined empirically by permutation analysis. For chromosomes 1 and 4, combined (– . . –) as well as specific interval maps for male
(—) and female (. . .) are shown.
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were detected in the distal third of chromosome 1 while the
QTL on chromosome 4 appears to be female-specific. How-
ever, follow-up studies using independent genetic designs
are necessary to confirm the sex-dependence of these QTL
as well as to verify each of the QTL identified in this initial
report.
There are several possible reasons why there is individual
variability in oral nicotine consumption in mice. One possible
explanation is that there is no real choice involved but rather,
mice that consume more nicotine do so simply because they
drink more overall fluid. If this were the case, there would be
a strong positive correlation between total fluid consumption
and nicotine consumption. However, there is a small and
negative correlation (r ¼ 0.295; P < 0.001) between these
two measures. The fact that there is an inverse correlation
between daily nicotine consumption and daily fluid consump-
tion argues that individual differences in nicotine consump-
tion are not due to individual differences in overall fluid
consumption. A second reason why mice may exhibit differ-
ences in nicotine consumption is taste; nicotine is classified
as a bitter taste. Therefore, there may be avoidance or
preference for nicotine based upon its taste rather than some
pharmacological effect. Although an influence of taste on
nicotine consumption cannot be entirely ruled out, we do not
believe that it is the major determinant for nicotine consump-
tion based upon the following information. First, QTL for bitter
taste have been mapped in mice (Harder and Whitney 1998;
Le Roy et al. 1999) and none of these QTL map to the same
chromosomal regions as the QTL for nicotine consumption.
Second, there are no known taste receptor genes located
within the confidence intervals of the four nicotine consump-
tion QTL. Third, previous studies have demonstrated that
masking the taste of nicotine with saccharin does not alter the
rank order of nicotine consumption among inbred mouse
strains (Robinson et al. 1996). Finally, mice exhibit no
preference for the less biologically active stereoisomer of
nicotine (Butt et al. 2005). These combined results indicate
that individual differences in nicotine consumption are likely
due to a pharmacological effect of the drug (either adverse or
reinforcing). This conclusion is further supported by studies
which demonstrate that oral nicotine preference is reduced
when animals are pretreated with a nicotinic receptor antag-
onist (Glick et al. 1996). The observation that nicotine
consumption is reduced by a nicotinic antagonist suggests
that oral nicotine consumption is due to the reinforcing
properties of the drug and not its aversive effects.
Previously, we have demonstrated that there is a significant
genetic correlation between alcohol consumption and nico-
tine consumption in C57BL/6  C3H F2 intercross mice (Li
et al. 2005). Moreover, nicotine consumption in inbred mouse
strains (data from Butt et al., 2005) is significantly correlated
with both preference for a solution containing 10% ethanol
(Belknap et al. 1993) (n ¼ 9, r2 ¼ 0.726, P < 0.05) and
withdrawal from chronic ethanol exposure (Metten et al.
1998) (n ¼ 9, r2 ¼ 0.707, P < 0.05) (data not shown). These
data suggest that there is genetic overlap between nicotine
consumption, alcohol consumption and withdrawal from
alcohol. Consistent with this possibility, all four significant
QTL for nicotine consumption overlap with previous QTL
identified for either alcohol preference or alcohol withdrawal.
For example, two QTL for ethanol withdrawal (Buck et al.
1997; 2002) exhibit peak LOD scores very near or identical to
the regions of chromosomes 1 and 4 where we report peak
LOD scores for QTL for nicotine consumption. In addition,
QTL for both nicotine consumption and alcohol preference are
located in proximal chromosome 7 (Bachmanov et al. 2002)
and central/distal chromosome 15 (Vadasz et al. 2000; Gill and
Boyle 2005). Interestingly, for the QTL on chromosome 7, the
relationship between genotype and phenotype is opposite
that of the parental strains for both nicotine and alcohol
consumption. This observation suggests that there is a ‘pro-
tective’ allele or alleles on proximal chromosome 7 that
reduces drug consumption in the high drug consuming
C57BL/6 mouse strain.
In humans, there is high co-morbidity between alcoholism
and smoking (Istvan and Matarazzo 1984; Battjes 1988). In
addition, a large number of studies clearly have established
that there is a strong genetic influence on both smoking
and alcoholism (Istvan and Matarazzo 1984; Carmelli et al.
1990; Swan et al. 1990; Heath et al. 1993; Heath and Martin
1993; Hettema et al. 1999). Moreover, True et al. (1999)
reported that there are common genetic influences on
both alcoholism and smoking and Bergen and Caporaso
(1999) identified common loci that show evidence for
linkage to both smoking and alcoholism. These findings
suggest that alcohol and nicotine dependence may be
influenced, in part, by genetic variability in common genes.
The fact that QTL for both alcohol- and nicotine-related
behaviors map to the same regions of chromosomes 1, 4, 7
and 15 in mice also support this possibility. Consequently,
establishing whether the same gene or genes in these
chromosomal regions do, in fact, influence both nicotine-
and alcohol-related behaviors may provide insight into the
molecular genetic basis for the co-morbidity between smok-
ing and alcoholism.
In summary, free-choice oral nicotine consumption in
mice appears to be strongly influenced by genetic factors.
The data reported here suggest that four QTL account for up
to 62% of the variance in nicotine consumption. Although
follow-up studies are necessary to confirm these QTL, future
studies to identify the genes that underlie the verified QTL
will provide insight into the molecular basis of individual
differences in nicotine and perhaps alcohol consumption.
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